T-Cell Immunity and COVID-19—Anthony Tanoto Tan—Duke-NUS Medical School
Finding Genius Podcast
Richard Jacobs
4.4 • 1K Ratings
🗓️ 2 September 2020
⏱️ 49 minutes
🧾️ Download transcript
Summary
Senior Research Fellow at Duke-NUS Medical School, Dr. Anthony Tanoto Tan, discusses his work in the field of immunopathology as it relates to both hepatitis B and the SARS-CoV-2 virus responsible for the COVID-19 situation.
In this episode, you will learn:
- What role T cells play in the immune response to infectious diseases, and how they store "memory" of certain pathogens
- How T cells differ from antibodies, in general and in the context of COVID-19
- What it might mean that people who have never been exposed to the SARS-coV-2 virus have specific T cells for it
For the past 10 to 15 years, Dr. Tan has been trying to understand the immune system response to disease, and its role in clearing infectious diseases. With a special focus on hepatitis B, which causes an infection and can proceed to liver cancer, he ended up researching adaptive T-cell therapy for liver cancer.
With expertise in the analysis of virus-specific T cells, Dr. Tan and his team began researching the T cell response to the SARS-CoV-2 virus with the goal of determining whether there are differences in the immune response in people who are asymptomatic or have a mild case of the virus, and people who develop severe symptoms. They are also trying to understand how the T cell response changes over time, from the acute phase of the infection through to resolution of the infection.
Dr. Tan discusses the details of his recent publication on this research, which shows that people who were infected with SARS-CoV-1 17 years ago still have SARS-CoV-1-specific T cells. Not surprisingly, SARS-CoV-2-specific T cells were found in individuals who have been infected with SARS-CoV-2. Of particular interest is the finding that people who have NOT been exposed to either virus were shown to have SARS-CoV-2-specific T cells.
This suggests that a proportion of unexposed individuals have a preexisting immune response to the virus that's causing COVID-19. Whether the function of this immune response is protective is the question that remains.
In addition to these topics, Dr. Tan talks about the processes in innate and adaptive immunity, how T cells behave during pathogenesis, what causes T cells to have a faster response to infected cells, which proteins to target with a vaccination, and much more.
Available on Apple Podcasts: apple.co/2Os0myK
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Forget frequently asked questions common sense common knowledge or Google how about advice from a real genius |
| 0:06.8 | 95% of people in any profession are good enough to be qualified and licensed 5% go and beyond. They become very good at what they do, but only 0.1% are real Jesus. |
| 0:18.3 | Richard Jacobs has made it his life's mission to find them for you. He hunts down and interviews geniuses in every |
| 0:24.7 | field, sleep science, cancer, stem cells, ketogenic diets and more. Here come the geniuses. |
| 0:30.1 | This is the Finding Genius Podcast. |
| 0:33.0 | That is Richard Jacobs. |
| 0:35.0 | Hello, this is Richard Jacobs |
| 0:40.0 | with the Finding Genius Podcast. |
| 0:42.0 | My guest today is 10 Anthony Tenato he's a senior research |
| 0:46.1 | fellow at Duke and US Medical School he's interested in hepatitis B virus H.B. |
| 0:52.2 | The immunology of it. |
| 0:54.4 | And there's some links to COVID-19 or SARS-Cobi-2 |
| 0:59.3 | and had to possibly use the body's own immune cells to target viruses or virus |
| 1:04.8 | infecting cells. Dan, thanks for coming. How you doing? I'm good. Thank you very |
| 1:08.8 | much for inviting. Yeah. Well, if you would tell me in your own words, what's your research about? |
| 1:14.0 | So my research has been focused primarily on hepatitis B, and to understand the immune pathology, |
| 1:23.5 | which is how the immune system causes the disease, |
| 1:28.4 | and also how the immune system is involved |
| 1:31.1 | in curing or clearing the disease itself. |
| 1:35.1 | So it started from there. |
| 1:37.4 | I've been working on it for the past 10 to 15 years. And those work we started to enter into the field of adoptive |
| 1:48.2 | cell therapy and since Hepatitis B causes not only a infection, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Richard Jacobs, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Richard Jacobs and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.